The neuropathic pain triad: neurons, immune cells and glia

Nociceptive pain results from the detection of intense or noxious stimuli by specialized high-threshold sensory neurons (nociceptors), a transfer of action potentials to the spinal cord, and onward transmission of the warning signal to the brain. In contrast, clinical pain such as pain after nerve injury (neuropathic pain) is characterized by pain in the absence of a stimulus and reduced nociceptive thresholds so that normally innocuous stimuli produce pain. The development of neuropathic pain involves not only neuronal pathways, but also Schwann cells, satellite cells in the dorsal root ganglia, components of the peripheral immune system, spinal microglia and astrocytes. As we increasingly appreciate that neuropathic pain has many features of a neuroimmune disorder, immunosuppression and blockade of the reciprocal signaling pathways between neuronal and non-neuronal cells offer new opportunities for disease modification and more successful management of pain.

[1]  T. Nakatsuka,et al.  ATP P2X Receptor-Mediated Enhancement of Glutamate Release and Evoked EPSCs in Dorsal Horn Neurons of the Rat Spinal Cord , 2001, The Journal of Neuroscience.

[2]  Richard O Jenkins,et al.  Toxicology of fluoroacetate: a review, with possible directions for therapy research , 2006, Journal of applied toxicology : JAT.

[3]  Yi Dai,et al.  Neurons and glial cells differentially express P2Y receptor mRNAs in the rat dorsal root ganglion and spinal cord , 2006, The Journal of comparative neurology.

[4]  R. Coggeshall,et al.  Blocking Caspase Activity Prevents Transsynaptic Neuronal Apoptosis and the Loss of Inhibition in Lamina II of the Dorsal Horn after Peripheral Nerve Injury , 2005, The Journal of Neuroscience.

[5]  J. McArthur,et al.  Schwann cell chemokine receptors mediate HIV‐1 gp120 toxicity to sensory neurons , 2003, Annals of neurology.

[6]  R. Myers,et al.  TNFα-induced MMP-9 promotes macrophage recruitment into injured peripheral nerve , 2006, Molecular and Cellular Neuroscience.

[7]  M. Tsuda,et al.  Neuropathic pain and spinal microglia: a big problem from molecules in ‘small’ glia , 2005, Trends in Neurosciences.

[8]  Yi Dai,et al.  Differential expression patterns of mRNAs for P2X receptor subunits in neurochemically characterized dorsal root ganglion neurons in the rat , 2005, The Journal of comparative neurology.

[9]  Y. Chen,et al.  Neuronal somatic ATP release triggers neuron–satellite glial cell communication in dorsal root ganglia , 2007, Proceedings of the National Academy of Sciences.

[10]  R J Miller,et al.  Chemokines and Glycoprotein120 Produce Pain Hypersensitivity by Directly Exciting Primary Nociceptive Neurons , 2001, The Journal of Neuroscience.

[11]  S. Beggs,et al.  Stereological and somatotopic analysis of the spinal microglial response to peripheral nerve injury , 2007, Brain, Behavior, and Immunity.

[12]  R Weinberg,et al.  New Concepts... , 1995 .

[13]  S. Maier,et al.  Fractalkine (CX3CL1) and fractalkine receptor (CX3CR1) distribution in spinal cord and dorsal root ganglia under basal and neuropathic pain conditions , 2004, The European journal of neuroscience.

[14]  S. Maier,et al.  Evidence that exogenous and endogenous fractalkine can induce spinal nociceptive facilitation in rats , 2004, The European journal of neuroscience.

[15]  S. Akira,et al.  A Critical Role of Toll-like Receptor 2 in Nerve Injury-induced Spinal Cord Glial Cell Activation and Pain Hypersensitivity* , 2007, Journal of Biological Chemistry.

[16]  Y. Shavit,et al.  Genetic impairment of interleukin-1 signaling attenuates neuropathic pain, autotomy, and spontaneous ectopic neuronal activity, following nerve injury in mice , 2006, Pain.

[17]  R. Ji,et al.  Role of the CX3CR1/p38 MAPK pathway in spinal microglia for the development of neuropathic pain following nerve injury-induced cleavage of fractalkine , 2007, Brain, Behavior, and Immunity.

[18]  J. Corbett,et al.  Expression of Neuregulins and their Putative Receptors, ErbB2 and ErbB3, Is Induced during Wallerian Degeneration , 1997, The Journal of Neuroscience.

[19]  C. Cooper,et al.  A multicentre randomized controlled trial of epidural corticosteroid injections for sciatica: the WEST study. , 2005, Rheumatology.

[20]  R. LaMotte,et al.  Excitatory monocyte chemoattractant protein-1 signaling is up-regulated in sensory neurons after chronic compression of the dorsal root ganglion. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[21]  Guido Stoll,et al.  Degeneration and regeneration of the peripheral nervous system: From Augustus Waller's observations to neuroinflammation , 2002, Journal of the peripheral nervous system : JPNS.

[22]  F. Cunha,et al.  A cascade of cytokines mediates mechanical inflammatory hypernociception in mice. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[23]  P. Anand,et al.  Disruption of the P2X7 purinoceptor gene abolishes chronic inflammatory and neuropathic pain , 2005, Pain.

[24]  S. Bevan,et al.  Inhibition of spinal microglial cathepsin S for the reversal of neuropathic pain , 2007, Proceedings of the National Academy of Sciences.

[25]  B. Aggarwal.  Signalling pathways of the TNF superfamily: a double-edged sword , 2003, Nature Reviews Immunology.

[26]  Kirk W. Johnson,et al.  Repeated intrathecal injections of plasmid DNA encoding interleukin-10 produce prolonged reversal of neuropathic pain , 2006, Pain.

[27]  V. Tawfik,et al.  Efficacy of propentofylline, a glial modulating agent, on existing mechanical allodynia following peripheral nerve injury , 2007, Brain, Behavior, and Immunity.

[28]  Robert W. Gereau,et al.  Acute p38-Mediated Modulation of Tetrodotoxin-Resistant Sodium Channels in Mouse Sensory Neurons by Tumor Necrosis Factor-α , 2006, The Journal of Neuroscience.

[29]  E. Ringelstein,et al.  Rapid response of identified resident endoneurial macrophages to nerve injury. , 2001, The American journal of pathology.

[30]  T. Brennan,et al.  A-317491, a novel potent and selective non-nucleotide antagonist of P2X3 and P2X2/3 receptors, reduces chronic inflammatory and neuropathic pain in the rat , 2002, Proceedings of the National Academy of Sciences of the United States of America.

[31]  H. Koerber,et al.  Glial Cell Line-Derived Neurotrophic Factor Family Members Sensitize Nociceptors In Vitro and Produce Thermal Hyperalgesia In Vivo , 2006, The Journal of Neuroscience.

[32]  E. McLachlan,et al.  Distinct functional types of macrophage in dorsal root ganglia and spinal nerves proximal to sciatic and spinal nerve transections in the rat , 2003, Experimental Neurology.

[33]  R. Coggeshall,et al.  Delayed loss of small dorsal root ganglion cells after transection of the rat sciatic nerve , 2000, The Journal of comparative neurology.

[34]  S. Summerfield,et al.  Investigation into the role of P2X3/P2X2/3 receptors in neuropathic pain following chronic constriction injury in the rat: an electrophysiological study , 2006, British journal of pharmacology.

[35]  Linda R Watkins,et al.  Beyond neurons: evidence that immune and glial cells contribute to pathological pain states. , 2002, Physiological reviews.

[36]  J. Geddes,et al.  What is a randomised controlled trial? , 2009, Epidemiologia e Psichiatria Sociale.

[37]  M. Dorf,et al.  Astrocytes express functional chemokine receptors , 2000, Journal of Neuroimmunology.

[38]  Richard J. Miller,et al.  Chemokines: Integrators of Pain and Inflammation , 2005, Nature Reviews Drug Discovery.

[39]  B. Khakh.  Molecular physiology of p2x receptors and atp signalling at synapses , 2001, Nature Reviews Neuroscience.

[40]  Yves De Koninck,et al.  Trans-synaptic shift in anion gradient in spinal lamina I neurons as a mechanism of neuropathic pain , 2003, Nature.

[41]  D. Donnelly-roberts,et al.  Discovery of P2X7 receptor‐selective antagonists offers new insights into P2X7 receptor function and indicates a role in chronic pain states , 2007, British journal of pharmacology.

[42]  D. Tracey,et al.  Hyperalgesia due to nerve injury: role of neutrophils , 2000, Neuroscience.

[43]  C. Kalkman,et al.  The PINE study of epidural steroids and local anaesthetics to prevent postherpetic neuralgia: a randomised controlled trial , 2006, The Lancet.

[44]  John (Sam) Keltner,et al.  Facilitation , 1989, Abécédaire de la philosophie pour enfants.

[45]  K. Kataoka,et al.  Differential regulation of microglial activation by propentofylline via cAMP signaling , 1998, Brain Research.

[46]  L. Koetzner,et al.  Pharmacological and pharmacokinetic characterization of the cannabinoid receptor 2 agonist, GW405833, utilizing rodent models of acute and chronic pain, anxiety, ataxia and catalepsy , 2005, Neuropharmacology.

[47]  J. Deleo,et al.  Inhibition of Microglial Activation Attenuates the Development but Not Existing Hypersensitivity in a Rat Model of Neuropathy , 2003, Journal of Pharmacology and Experimental Therapeutics.

[48]  J. Deleo,et al.  The active metabolite of leflunomide, an immunosuppressive agent, reduces mechanical sensitivity in a rat mononeuropathy model. , 2002, The journal of pain : official journal of the American Pain Society.

[49]  H. Thoenen,et al.  Interleukin-1 regulates synthesis of nerve growth factor in non-neuronal cells of rat sciatic nerve , 1987, Nature.

[50]  J. Alberta,et al.  Microanatomy of Axon/Glial Signaling during Wallerian Degeneration , 2005, The Journal of Neuroscience.

[51]  Xin-Fu Zhou,et al.  Isolation and Characterization of Neural Crest Progenitors from Adult Dorsal Root Ganglia , 2007, Stem cells.

[52]  L. Sorkin,et al.  Increased Sensitivity of Injured and Adjacent Uninjured Rat Primary Sensory Neurons to Exogenous Tumor Necrosis Factor-α after Spinal Nerve Ligation , 2003, The Journal of Neuroscience.

[53]  W. Ma,et al.  Cyclooxygenase 2 in infiltrating inflammatory cells in injured nerve is universally up-regulated following various types of peripheral nerve injury , 2003, Neuroscience.

[54]  Yi Dai,et al.  Activation of Src-Family Kinases in Spinal Microglia Contributes to Mechanical Hypersensitivity after Nerve Injury , 2006, The Journal of Neuroscience.

[55]  K. Keay,et al.  Immune cell involvement in dorsal root ganglia and spinal cord after chronic constriction or transection of the rat sciatic nerve , 2007, Brain, Behavior, and Immunity.

[56]  A. Marshak‐Rothstein.  Toll-like receptors in systemic autoimmune disease , 2006, Nature Reviews Immunology.

[57]  Ji Zhang,et al.  Characterization of cell proliferation in rat spinal cord following peripheral nerve injury and the relationship with neuropathic pain , 2008, PAIN®.

[58]  B. Winkelstein,et al.  Nerve injury proximal or distal to the DRG induces similar spinal glial activation and selective cytokine expression but differential behavioral responses to pharmacologic treatment , 2001, The Journal of comparative neurology.

[59]  M. Lauritzen,et al.  Evidence for nitric oxide and nitric oxide synthase activity in proximal stumps of transected peripheral nerves , 1999, Neuroscience.

[60]  Geoffrey Burnstock,et al.  Physiology and pathophysiology of purinergic neurotransmission. , 2007, Physiological reviews.

[61]  C. Woolf,et al.  ERK is sequentially activated in neurons, microglia, and astrocytes by spinal nerve ligation and contributes to mechanical allodynia in this neuropathic pain model , 2005, Pain.

[62]  A. Höke,et al.  Spatially distinct and functionally independent mechanisms of axonal degeneration in a model of HIV-associated sensory neuropathy. , 2006, Brain : a journal of neurology.

[63]  S. Maier,et al.  Minocycline attenuates mechanical allodynia and proinflammatory cytokine expression in rat models of pain facilitation , 2005, Pain.

[64]  A. Majid,et al.  The Potential of Minocycline for Neuroprotection in Human Neurologic Disease , 2004, Clinical neuropharmacology.

[65]  J. Mudgett,et al.  Impaired neuropathic pain responses in mice lacking the chemokine receptor CCR2 , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[66]  C. Gravel,et al.  BDNF from microglia causes the shift in neuronal anion gradient underlying neuropathic pain , 2005, Nature.

[67]  I. Chessell,et al.  The Voltage-Gated Sodium Channel Nav1.9 Is an Effector of Peripheral Inflammatory Pain Hypersensitivity , 2006, The Journal of Neuroscience.

[68]  J. Deleo,et al.  Intrathecal anti-IL-6 antibody and IgG attenuates peripheral nerve injury-induced mechanical allodynia in the rat: possible immune modulation in neuropathic pain 1 1 Published on the World Wide Web on 28 August 2000. , 2000, Brain Research.

[69]  M. Ramer,et al.  Spinal nerve lesion-induced mechanoallodynia and adrenergic sprouting in sensory ganglia are attenuated in interleukin-6 knockout mice , 1998, Pain.

[70]  T. Umapathi,et al.  Toxic neuropathy , 2005, Current opinion in neurology.

[71]  Mario Saltarelli,et al.  Advances in neuropathic pain: diagnosis, mechanisms, and treatment recommendations. , 2003, Archives of neurology.

[72]  P Bailey,et al.  Double Edged Sword , 2002 .

[73]  Y. Koninck,et al.  Spatial and temporal relationship between monocyte chemoattractant protein‐1 expression and spinal glial activation following peripheral nerve injury , 2006, Journal of neurochemistry.

[74]  C. Sommer,et al.  Thalidomide treatment in chronic constrictive neuropathy decreases endoneurial tumor necrosis factor-α, increases interleukin-10 and has long-term effects on spinal cord dorsal horn met-enkephalin , 2000, PAIN.

[75]  P. Rezaie,et al.  The origin and cell lineage of microglia—New concepts , 2007, Brain Research Reviews.

[76]  W. Streit.  Microglia as neuroprotective, immunocompetent cells of the CNS , 2002, Glia.

[77]  M. Caterina,et al.  A proinflammatory chemokine, CCL3, sensitizes the heat- and capsaicin-gated ion channel TRPV1. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[78]  L. Sorkin,et al.  Tumor necrosis factor-alpha induces mechanical allodynia after spinal nerve ligation by activation of p38 MAPK in primary sensory neurons. , 2003, The Journal of neuroscience : the official journal of the Society for Neuroscience.

[79]  C. Woolf,et al.  p38 Mitogen-Activated Protein Kinase Is Activated after a Spinal Nerve Ligation in Spinal Cord Microglia and Dorsal Root Ganglion Neurons and Contributes to the Generation of Neuropathic Pain , 2003, The Journal of Neuroscience.

[80]  A. Sher,et al.  Cooperation of Toll-like receptor signals in innate immune defence , 2007, Nature Reviews Immunology.

[81]  M. Avilés-Trigueros,et al.  Involvement of monocyte chemoattractant protein-1, macrophage inflammatory protein-1α and interleukin-1β in Wallerian degeneration , 2005 .

[82]  F. Di Virgilio,et al.  Nucleotide receptors: an emerging family of regulatory molecules in blood cells. , 2001, Blood.

[83]  S. McMahon,et al.  Role of the Immune system in chronic pain , 2005, Nature Reviews Neuroscience.

[84]  J. Deleo,et al.  The CNS role of Toll-like receptor 4 in innate neuroimmunity and painful neuropathy. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[85]  R. Myers,et al.  The effect of thalidomide treatment on vascular pathology and hyperalgesia caused by chronic constriction injury of rat nerve , 1998, Pain.

[86]  T. Hökfelt,et al.  Effect of peripheral nerve injury on dorsal root ganglion neurons in the C57 BL/6J mouse: marked changes both in cell numbers and neuropeptide expression , 2001, Neuroscience.

[87]  C. Saab,et al.  Neutrophils invade lumbar dorsal root ganglia after chronic constriction injury of the sciatic nerve , 2007, Journal of Neuroimmunology.

[88]  L. Huang,et al.  Mechanisms underlying enhanced P2X receptor-mediated responses in the neuropathic pain state , 2005, Pain.

[89]  R. Mirsky,et al.  Denervated Schwann Cells Attract Macrophages by Secretion of Leukemia Inhibitory Factor (LIF) and Monocyte Chemoattractant Protein-1 in a Process Regulated by Interleukin-6 and LIF , 2002, The Journal of Neuroscience.

[90]  S. Koizumi,et al.  P2X4 receptors induced in spinal microglia gate tactile allodynia after nerve injury , 2003, Nature.

[91]  S. Maier,et al.  GLIA: A novel drug discovery target for clinical pain , 2003, Nature Reviews Drug Discovery.

[92]  M. Hanani.  Satellite glial cells in sensory ganglia: from form to function , 2005, Brain Research Reviews.

[93]  V. Perry,et al.  Wallerian degeneration of injured axons and synapses is delayed by a Ube4b/Nmnat chimeric gene , 2001, Nature Neuroscience.

[94]  R. Myers,et al.  The role of neuroinflammation in neuropathic pain: mechanisms and therapeutic targets. , 2006, Drug discovery today.

[95]  S. McMahon,et al.  Role of spinal microglia in rat models of peripheral nerve injury and inflammation , 2007, European journal of pain.

[96]  Clifford J. Woolf,et al.  Complement Induction in Spinal Cord Microglia Results in Anaphylatoxin C5a-Mediated Pain Hypersensitivity , 2007, The Journal of Neuroscience.

[97]  J. Loeb,et al.  Rapid Axoglial Signaling Mediated by Neuregulin and Neurotrophic Factors , 2004, The Journal of Neuroscience.

[98]  C. Svensson,et al.  Spinal p38β isoform mediates tissue injury‐induced hyperalgesia and spinal sensitization , 2005, Journal of neurochemistry.

[99]  M. Jarvis,et al.  Antinociceptive properties of a non-nucleotide P2X3/P2X2/3 receptor antagonist. , 2005, Drug news & perspectives.

[100]  D. Donnelly-roberts,et al.  P2X7-related modulation of pathological nociception in rats , 2007, Neuroscience.

[101]  Michael Costigan,et al.  Replicate high-density rat genome oligonucleotide microarrays reveal hundreds of regulated genes in the dorsal root ganglion after peripheral nerve injury. , 2002, BMC Neuroscience.

[102]  N. Stella.  Cannabinoid signaling in glial cells , 2004, Glia.